Scientists develop artificial bone marrow

Image
Press Trust of India Berlin
Last Updated : Jan 12 2014 | 12:55 PM IST
German scientists have developed artificial bone marrow that allows stem cells to multiply and may simplify the treatment of leukaemia.
The porous structure possesses essential properties of natural bone marrow and can be used for the reproduction of stem cells at the laboratory.
This might facilitate the treatment of leukaemia in a few years, researchers said.
Scientists at Karlsruhe Institute of Technology (KIT), the Max Planck Institute for Intelligent Systems, Stuttgart, and Tubingen University developed the synthetic material that allows stem cells to multiply.
Blood cells, such as erythrocytes or immune cells, are continuously replaced by new ones supplied by hematopoietic stem cells located in a specialised niche of the bone marrow.
Hematopoietic stem cells can be used for the treatment of blood diseases, such as leukemia. The affected cells of the patient are replaced by healthy hematopoietic stem cells of an eligible donor.
However, not every leukaemia patient can be treated in this way, as the number of appropriate transplants is not sufficient.
This problem might be solved by the reproduction of hematopoietic stem cells. So far, this has been impossible, as these cells retain their stem cell properties in their natural environment only, ie in their niche of the bone marrow.
Researchers artificially reproduced major properties of natural bone marrow at the laboratory.
With the help of synthetic polymers, scientists created a porous structure simulating the sponge-like structure of the bone in the area of the blood-forming bone marrow.
They added protein building blocks similar to those existing in the matrix of the bone marrow for the cells to anchor.
The scientists also inserted other cell types from the stem cell niche into the structure in order to ensure substance exchange.
Researchers introduced hematopoietic stem cells isolated from cord blood into this artificial bone marrow. Subsequent breeding of the cells took several days.
Analyses with various methods revealed that the cells really reproduce in the newly developed artificial bone marrow. Compared to standard cell cultivation methods, more stem cells retain their specific properties in the artificial bone marrow.
The study appears in the journal Biomaterials.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jan 12 2014 | 12:55 PM IST

Next Story